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Abstract 
 In an attempt to find potential functional foods in Tanzania, a study was conducted to assess bioactivity of 18 
ethyl acetate extracts from nine (9)  Ascomycetes strains. Namely; Candida tropicalis, C. pararugosa, 
Clavispora lusitaniae, Issatchenkia orientalis, Pichia kudriavzevii, Pichia guilliermondii, Galactomyces 
geotricum, Debaryomyces hansenii and Yarrowia lipolytica isolated from traditional fermented milk “mtindi”. 
Lethality test of the extracts was determined using Artemia salina naupalii in a Brine Shrimp Test (BST). The 
lethal concentration (LC50) obtained ranged from 89.7µg/ml to over 1000 µg/ml.  Bioactivity results showed that, 
one of the 18 extracts had exhibited a strong antibacterial activity against Staphylococcus aureus, Pseudomonas 
aureginosa and Vibrio cholera having minimum inhibitory concentration (MIC) values of 0.1653mg/ml on each 
account.  More than 40% of extracts exhibited strong to moderate antifungal activity against Cryptococcus 
neoformans (MIC 0.16 mg/ml – 1.25 mg/ml). In conclusion, these results suggest that yeasts found in traditional 
fermented milk have potential biological activity that could be used for treatment of some diarrhoeal and fungal 
infections and possibly tuberculosis.  
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1. Introduction 
Antibiotic resistant and infectious diseases are becoming a major public health concern worldwide. Misuse of 
antibiotics has turned out to be a common phenomenon leading to development of multi-drugs resistance against 
pathogens, which may eventually result in common infections becoming untreatable (Akabanda and Glover, 
2010).  Fermented dairy products have played an important role in human nutrition for centuries and when 
administered in adequate amount, they can confer a health benefit on the host (Stanton et al., 2005). Lactic acid 
bacteria (LAB) fermentation has a long history and reported as effective bio-preservation with abundant of 
literature on its antimicrobial activities against food borne pathogens (Yang et al., 2012; Mufandaedza et al.2006; 
Kuwabara et al., 1995).   
“Mtindi” is a Tanzanian traditional fermented milk  that is prepared by two major methods; first, is by 
spontaneously fermentation of raw milk at ambient temperature in different types of containers such as 
earthenware pots, gourds and in some semi-urban areas plastic containers, then covered and placed inside the hut 
or house to ferment for 24 to 36 hours. The containers are normally not sanitized after every fermentation cycle 
and are usually reused for the same purpose.  The Maasai would store milk in gourds and chopped and burnt 
pieces of woods would be added to give it a smoky flavour. The milk usually fermented promptly after being 
added into the gourds (Isono and  Shjngu, 1994).The second type of mtindi is produced through the addition of a 
portion of the remnant of previously fermentation into warm milk which was previously boiled (back-slopping). 
The inoculated milk is covered and left to ferment for about 12 hours.   
 
Like most traditionally fermented products, the specific microflora in mtindi is unpredictable from one 
fermentation cycle to the next and therefore wavering in its quality (Lourens-Hattingh and  Viljoen, 2002; 
Savova and  Nikolova, 2002). Lactic acid bacteria (LAB), yeasts and coliforms have been found to coexists in 
traditionally fermented milk (Paucean et al.,  2010; Gran et al.,  2003; Narvhus, 2001). The low pH and the 
presence of antimicrobial substances from fermenters reckon traditional fermented milk safe (Samet-bali et al., 
2012; Stanton et al., 2005). Both popular wisdom and some research findings have acclaimed fermented milk to 
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be more nutritious and health-promoting than fresh milk (Akabanda and Glover, 2010). The consumption of 
fermented dairy products was reported to have attributed to the longevity of Bulgarians (Yesillik et al., 2011; 
Stanton et al., 2005). Traditional fermented milk containing yeasts as part of microflora or starter culture has 
been associated with the  treatment of colitis and diarrhoeal diseases in ( Ni et al. 2007; Dixit and Gandhi, 2006; 
Mufandaedza et al., 2006; Jespersen, 2003) and even tuberculosis in Russia during post World War II era (Lopitz 
et al., 2006).  
Yeasts are reported to play favourable effects in fermented milk over most bacteria due to low pH and secretion 
of bioactive substances (Lourens-Hattingh and Viljoen, 2002; Savova and Nikolova, 2002). Health benefits of 
traditional fermented milk can therefore be expressed either  through the interaction of ingested live bacteria or 
yeasts with the host or is a result of ingestion of metabolites such as organic acids, antibiotic factors and volatile 
acids produced by fermenters during the fermentation process (Stanton et al., 2005).  It can therefore be 
speculated that, the more diverse the yeasts are in fermented milk the higher is the potential of getting more 
bioactive metabolites against various food borne pathogens. However, to our knowledge a limited number of 
studies have investigated the antimicrobial activities of food-borne pathogens by natural yeasts isolated from 
dairy products and their mechanisms.  
The aim of the present study was to evaluate the antimicrobial activity of crude extracts of yeasts isolated from 
traditional fermented milk against selected human pathogens, Gram-positive, Gram-negative bacteria, and 
against a fungus. Investigation was carried out to establish whether claimed therapeutic effect of traditional 
fermented milk against diarrhoea, venereal diseases and tuberculosis could be attributed to metabolites from 
yeasts found in traditional fermented milk.  
 
2. Materials and Methods 
2.1 Fermented milk sampling  
Thirteen samples of traditional Tanzanian fermented milk, mtindi were purchased from local markets in Mwanza 
(Mw); n = 4) Dar es Salaam (Dar; n = 4), Morogoro (Moro; n=3), and Kilimanjaro (Kili; n=2) located in the 
North-western, Coastal, Eastern and Northern of Tanzania, respectively. Mtindi from Mwanza and Morogoro 
was prepared through spontaneous fermentation of raw milk at room temperature for 24 to 36 hours in non 
sanitized earthenware after previous fermentation, whereas, mtindi from Kilimanjaro and Dar es Salaam was 
made through addition of mtindi portions from previously fermentation in to warm, previous boiled milk and 
kept in well sanitized and covered plastic containers or buckets and left for 12 hours.  
 
2.2 Yeasts isolation and preliminary identification 
One gram of each yoghurt and ‘mtindi’ sample was diluted in 9 ml sterile 0.1% Ringer’s solution (0.9 % NaCl, 
0.042 % KCl, 0.48 % CaCl2.6H20, 0.02 % NaHC03, and 1 % Glucose) followed by decimal dilution up to 10-6 
and 1ml was used for pour plating in duplicate on malt extract agar,(MEA),  (HIMEDIA, India)  at 30 oC for 24 
hours. About 0.1 ml of 10-3, 10-5 and 10-6 dilutions each was spread on MEA plates supplemented with 
Chloromphenicol (100mg/l) to inhibit bacterial growth then incubated at 30 oC for 24 to 48 hours (Memmert, 
Depex B.V, The Netherlands). Yeast isolates per plate were selected based on their microscopic appearance, 
morphological differences, color, margin and elevation of the colonies (Kavas et al., 2006) further sub-cultured 
for 12 hours  at 30oC on Malt extract broth supplemented with Chloromphenicol (100 mg/l). After 12hrs, broth 
cultures were then streaked on malt extract agar plates supplemented with Chloromphenicol (100 mg/l) for 
purification. The strains were then cultured on malt extract slants at 30 oC for 24 to 48 hours and kept at 4 oC 
(KIKSVV33A; Robert Bosch, Germany). Eighteen yeasts strains recorded as Candida tropicalis (CtMw6), 
Candida pararugosa (Cp1Mw3, Cp2Mw4, Cp3Mw5), Pichia kudriavzevii (PkMw1), Clavispora lusitaniae 
(CllMw7), Issatchenkia orientalis (IoMw2), (NDMw8), Galactomyces geotricum (Gg1Dar1, Gg2Dar2, 
Gg3Dar3, Gg4Dar4, Gg5Kili1, Gg6kili2), Pichia guilliermondii (Pg1Moro, Pg2Dar5, Pg3Dar6) as identified by 
Mlimbila et al. (2013) were studied .  
 
2.3 Extraction of yeast secondary metabolites  
The process of extracting yeast metabolites is summarized diagrammatically in Figure 1. A loopful of pure yeast 
colonies were cultured for in 5 ml Malt extract broth HIMEDIA (Himedia Laboratories Pvt Ltd., Mumbai, India) 
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and incubated 12 hours. After 12 hours,  the culture was then introduced into 700 ml of sterile Malt extract broth 
and incubated at 30 oC for 14 days with shaking at 150 rpm only in the first 24 hours.  After two weeks, yeasts 
cells were filtered out using whatman’s filter paper (Sigma- Aldrich) and a filter funnel, leaving behind 
secondary crude metabolite in a filtrate. Metabolites were extracted by solvent extraction procedure using ethyl 
acetate (EtOAce) (Ranbaxy, New Delhi) as organic solvent. An equal volume of ethyl acetate and filtrate were 
taken in separating funnel and shaken vigorously by hands for about 45 minutes. The solution was left to stand 
until two distinct layers appeared. Ethyl acetate was evaporated using rotary evaporator at 40 oC, followed by 
vacuum drying to remove any remaining filtrate. Di-methyl sulphoxide (DMSO, Sigma Poole, Dorset, UK) was 
added to the extracts then stored at 0 oC in a refrigerator (KIKSVV33A; Robert Bosch, Germany) for further use.  
 
 
 
 
2.4 Brine shrimp lethality test 
The cytotoxicity activity of the extract was predicted using the brine shrimp lethality test (BST) as described by 
Meyer et al. (1982). Stock solutions of extracts were made by dissolving 20 mg of the crude extracts to 500 µl of 
DMSO to make up concentrations of 40 µg/ml each. Ten brine shrimp larvae were incubated in various extract 
concentrations (240, 120, 80, 40, 24 and 8 µg/ml) in duplicate vials for 24 hours (Brine shrimp eggs were 
purchased from Great Salt Lake, USA). Negative control was made by placing brine shrimps in a mixture of sea 
water and DMSO only.  The average number of survived brine shrimps was determined by examining the vials 
after 24 hours against the lighted background. Probity analysis was performed using SPSS 15.0 software where 
by the regression equation was obtained and used to determine concentration of extract that killed 50% of the 
larvae (LC50).  
 
2.5 Minimum Inhibitory Concentrations (MIC) determination. 
 The extracts were tested for in-vitro antibacterial activity against six bacteria: Staphylococcus aureus, NCTC 
6571, Streptococcus faecalis (clinical isolate), Pseudomonas aureginosa NCTC 10662, Mycobacterium 
smegmattis ATCC 14468, Escherichia coli NCTC 1066, Vibrio cholera (clinical isolate), and one fungus 
Cryptococcus neoformans (local clinical isolate). All Clinical isolates were obtained from the Department of 
Microbiolgy, Muhimbili University of Health and Allied Sciences (MUHAS). Minimum inhibitory 
concentrations were determined using micro-dilution techniques as described by Ellof (1998). The 96 well 
microtitre plates (Corning® Thermowell PCR 96 well plates, Sigma-Aldrich) were used for each yeast extract 
tested in duplicate at serial dilutions of 0.08, 0.16, 0.31, 0.625, 1.25, 2.5, 5 and 10 mg/ml. The first two columns 
were used for solvent controls while the last two for positive controls, Gentamycin Sulphate for bacteria and 
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Clotrimazole for fungus (0.024 – 50 µg/ml). In each well, 100µl of broth was added, followed by addition of 
50µl of crude extracts (100 mg/ml). Thereafter 50µl was drawn from each well in the first row and added into 
the next row downwards in all columns. Then 50µl of broth inoculated with test organism was added and then 
the plates were incubated overnight at 37
o
C.  Forty microlitres of 0.2mg/ml p-iodonitrotetrazolium chloride 
(NIT) dye were added into each well and incubated for another two hours. Plates were inspected for colour 
change; blue colour was an indication of microbial growth. The last wells in row in which there was no colour 
change were recorded as MICs.  
 
2.6 Data analysis 
Probity analysis was performed using SPSS 15.0 software which gives the regression equation. With regression 
equation LC50 were calculated at 95% confidence intervals. A  LC50 greater than 100µg/ml was considered to 
represent a non toxic extract (Moshi et al., 2010).  Proposed MIC was; up to 0.5 mg/ml was regarded as strong 
inhibitors, between 0.6 mg/ml to 1.5 mg/ml as moderate inhibitors and weak inhibitors when MIC is above 1.6 
mg/ml (Aligiannis et al., 2001). 
 
3. Results and Discussion 
3.1 Extract yield 
Results on the concentration of 18 yeasts crude extracts obtained from 14 day culture filtrates are presented in 
(Figure 1). Two yeast isolates from the Galactomyces group both originating from Kilimanjaro (Gg5Kili1, 
Gg6Kili2), one isolate from the Pichia group from Mwanza (PkMw1) and one isolate from the Candida group 
from Mwanza (Cp3Mw5) produced highest amounts of extract of 4290 µg/ml, 4100 µg/ml, 5100 µg/ml and 
4500 µg/ml, respectively. 
 
 
 
Figure 1: Amount of extract obtained from various volumes of 14 days culture filtrates, Origin of species: Dar- 
Dar es Salaam Moro-Morogoro Mw- Mwanza Kili- Kilimanjaro. Blue bars representing G. geotrichum, red bars 
representing Pichia and I. orientalis group and  green colored bars are for a group of  Candida and Cl. 
Lusitaniae. 
 
3.2 Brine Shrimps Lethality Test    
The brine shrimp lethality test results (Table 1) showed that LC50 of all 18 yeast extracts ranged from 87.9 µg/ml 
to over 1,000 µg/ml. Only two extracts from Cp3Mw5 (C. pararugosa) and Pg4Dar7 (G. geotrichum) showed 
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some toxicity by having LC50 values of 87.9 µg/ml and 99.0 µg/ml respectively. The remaining had LC50 values 
greater than 100 which is traditionally considered as non toxic (Moshi et al., 2010). Crude extract from isolate 
Gg6Kili2 exhibited by far the lowest cytotoxicity with LC50 of 1187.3µg/ml, followed by CtMw6 (LC50 410.0 
µg/ml) and Gg5Kili1 (LC50 350.9 µg/ml) (Table 1). According to Moshi et al. (2010), LC50 greater than 100 
µg/ml is considered non toxic. Toxicity of extract of mangrove P. guilliermondii  on human Celline had been 
reported by Joel and  Bhimba, (2013). Moshi and others in (2010) suggested that LC50 below 100µg/ml indicates 
toxic extracts which may be associated with anti-cancer activity. 
 
Table 1: Brine shrimp toxicity of Ethyl acetate extracts of yeast isolates from traditional fermented milk 
expressed as LC50 µg/ml (95% Confidence Interval) 
Extract Regression Equation  LC50 (µg/ml) 
Regression coefficient           
(R2) 
Gg1Dar1 y = 0.0036x + 0.117 106.4         0.737 
Gg2Dar2 y = 0.004x + 0.0469 113.3         0.8616 
Gg3Dar3 y = 0.002x + 0.2876 106.2         0.282 
Gg4Dar4 y = 0.0034x - 0.0504 132.2         0.9839 
Gg5Kili1 y = 0.0014x + 0.0087 350.9         0.6797 
Gg6Kili2 y = 0.0004x + 0.0251 1187.3         0.4692 
Pg1Moro y = 0.0037x + 0.0281 127.5         0.8785 
Pg2Dar5 y = 0.0036x - 0.0907 113.7         0.9067 
Pg3Dar6 y = 0.0035x + 0.0406 131.3         0.9102 
Pg4Dar7 y = 0.0045x + 0.0547 99.0*         0.7481 
PkMw1 y = 0.0033x + 0.028 143.0         0.8093 
IoMw2 y = 0.0028x + 0.0376 165.1         0.8322 
Cp1Mw3 y = 0.0028x + 0.0043 177.0         0.8904 
Cp2Mw4 y = 0.0025x - 0.0014 199.4         0.7876 
Cp3Mw5 y = 0.0027x + 0.2577 89.7*         0.4233 
CtMw6 y = 0.0012x + 0.008 410.0         0.8301 
CllMw7 y = 0.0027x - 0.0284 174.7         0.937 
NDMw8 y = 0.0032x - 0.063 136.6         0.9489 
* The toxic crude extracts on brine shrimp LC50 <100 µg/ml 
 
3.3 Antimicrobial activity  
Minimum inhibitory concentration analysis (Table 2) revealed promising activity against tested bacteria and 
fungus in 61% of all extracts (MIC < 1.25 mg/ml). All extracts from Candida and Cl. Lusitaniae, all from 
Mwanza region demonstrated the highest activity against C. neoformans having MIC < 1mg/ml and moderate 
activity agaisnt E. Coli and V. Cholera. Same extracts together with extracts from one of G. geotrichum from Dar 
es Salaam and P. guilliermondii (Pg1Moro) from Morogoro exhibited promising activity against Mycobacterium 
smegmattis with MIC of 1.25 mg/ml each.  
Extract of C. tropicalis CtMw6 had shown to exhibit the broadest antimicrobial activity against three bacteria S. 
aureus, P. aureginosa with MIC of 0.1563 mg/ml in both aspects and against M. smegmattis (MIC 1.25 mg/ml) 
and antifungal activity against C. neoformans (0.1563 mg/ml).  The extract of isolate Pg1Moro was the only one 
to exhibit promising activity against V. cholera with MIC of 1.25 mg/ml. Moreover, the same extract from P. 
gulliermondii from Morogoro region (Pg1Moro) and also I. Orientalis (IoMw2) had shown promising activity 
against E. coli (MIC, 1.25 mg/ml).  Of all Dar es Salaam samples, extracts from G. geotrichum (Gg1Dar1 and 
Gg2Dar2) TFMD1 and TFMD2 had promising bioactivity against C. neoformans and M. smegmattis, 
respectively (MIC, 1.25 mg/ml). Based on the argument by Alliagnis et al. (2001), an extract with MIC below 
0.5 mg/ml is regarded as strong inhibitor. 
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Table 2 : Antimicrobial activity of crude extracts from yeasts isolated from traditional fermented milk    expressed 
as minimum inhibitory concentration (MIC) (mg/ml) 
Yeast isolate 
extract 
Minimum Inhibitory Concentration (mg/ml) 
C. neoformas E. coli V. 
cholera S. aureus S. faecalis P. aureginosa 
M. 
smegmatis 
Gg1Dar1 5 - 2.5 5 2.5 5 1.25 
Gg2Dar2 1.25 5 5 10 10 - 5 
Gg3Dar3 5 5 5 10 5 - 5 
Gg4Dar4 5 5 5 10 5 - 5 
Gg5Kili1 - 5 5 5 5 - 5 
Gg6Kili2 5 5 5 10 10 - 5 
Pg1Moro 0.1563 - 1.25 - 2.5 - 1.25 
Pg2Dar5 5 5 5 10 10 - 5 
Pg3Dar6 5 5 5 10 10 - 5 
Pg4Dar7 5 5 5 5 10 - 10 
PkMw1 0.3125 - 2.5 5 2.5 2.5 1.25 
IoMw2 0.1563 1.25 2.5 5 2.5 5 1.25 
Cp1Mw3 0.625 2.5 2.5 2.5 5 5 1.25 
Cp2Mw4 0.3125 5 2.5 5 2.5 2.5 1.25 
Cp3Mw5 0.3125 1.25 2.5 5 2.5 2.5 1.25 
CtMw6 0.1563 - - 0.1563 5 0.156 1.25 
CllMw7 0.3125 - 2.5 5 2.5 2.5 1.25 
NDMw8 
Gentamycin 
0.625 
NA 
- 
0.003125 
2.5 
0.001563 
2.5 
0.000781 
5 
0.0000244 
5 
0.001563 
1.25 
NA 
 
In this study, majority of the crude extracts isolated from Mwanza fermented milk exhibited strong inhibition 
against C. neoformas and only one of the extracts against S. aureus and P. aurigenosa. Moderate activity against 
E. coli was exhibited by C. pararugosa (Cp5Mw5, MIC = 1.25). It is worth noting that in this research the same 
extracts with strong antifungal activities also exhibited considerable antibacterial activity (1.25 mg/ml) against 
M. smegmattis, a Tuberculosis (TB) causing organism. Antimicrobial activity of fermented milk is reported to be 
attributed to the microbial production of bioactive metabolites such as certain vitamins, bioactive peptides, 
organic acids or fatty acids during fermentation (Stanton et al., 2005). Indeed, a report by Mufandaedza et al. 
(2006) that Escherichia coli were significantly reduced in the traditionally fermented milk containing yeasts and 
bacteria from Zimbabwe is in support of our findings. 
Studies elsewhere have reported presence of antimicrobial agents in fermented milk which may play an 
important therapeutic role to consumers. A study by Yesillik et al., (2011) reported that homemade yoghurt 
inhibited the growth of P. aureginosa as compared to commercial yoghurt. Similarly, crude extracts of secondary 
metabolites of some yeasts such as P. guilliermondii have been reported  to exhibit promising  antimicrobial 
activity against various pathogenic microorganisms (Joel and Bhimba, 2013; Lahlali etal., 2011; Zhao et al., 
2010). It was reported in Russia that at the time post World War II, in areas where no medical facilities were 
available, kefir, fermented milk product  fermented by co-starter culture comprising of  Lactic acid bacteria 
(LAB) and yeasts was administered to TB patients  (Lopitz and  Aitor, 2006; Cevikbas et al., 1994). Mariam 
(2009) , reported that, filtrate from Ethiopian traditional fermented milk enriched with a mixture of Lactic acid 
bacteria (LAB) strains inhibited spiked M. bovis from the mixture in 14 day. Moreover, industrially fermented 
milk enriched with yeasts (kefir and koumiss) were claimed to treat gastrointestinal disorders when modern 
treatments was not available (Stanton et al., 2005).   
Yeasts found in several samples of African indigenous fermented foods and beverages are being related to 
improvement of nutritional value, pro-biotic effects and inhibition of undesired microorganisms (Paucean et al., 
2010, Jespersen, 2003; Stanton et al., 2005). It has also been reported that yoghourt enriched with yeasts produce 
bio-therapeutic agents effective in treatment of diarrhoea in children and critically ill tube fed patients (Lim & 
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Tay, 2011;Yesillik et al., 2011; Dixit and Gandhi, 2006). Results from this study echoes the important role played 
by microorganisms found in fermented milk. Generally our results revealed that extracts from the studied yeast 
strains  have high potential to be used as bio-therapeutic agents  since more than 80%  had either or/and  strong 
to weak activity against all tested pathogens  and were found to be non- toxic.  
4. Conclusion  
In this study, crude extract from yeasts isolated from Tanzanian ‘mtindi’ which was made through spontaneous 
fermentation of raw milk were found to be effective against some of the bacterial and fungal strains studied. It 
may be suggested from these findings that these extracts can be a potential source of natural antimicrobial 
compounds.  The identification of the bio-active group of the extracts will provide the basis for further research 
on the actual active compounds’ names and chemical structures. 
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